News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Early Rate Deadline Tomorrow for Clinical Trials Course for Non-Statisticians – EORTC
EORTC/LinkedIn
Apr 11, 2025, 06:49

Early Rate Deadline Tomorrow for Clinical Trials Course for Non-Statisticians – EORTC

EORTC – European Organisation for Research and Treatment of Cancer shared on LinkedIn:

“Early Rate Deadline tomorrow

This course is aimed at non-statisticians who work in clinical research or at statisticians with little or no experience in clinical trials.

Date: 10-13 June 2025.

Apply now.”

cancer clinical research clinical trials EORTC OncoDaily Oncology
Special Coverage
Blog
Apr 14, 2025, 08:50
Abbirami Sathappan: Introducing MENA ART 2025 - 'Innovation in Flow Cytometry and Microscopy'
Blog
Apr 14, 2025, 08:48
Roberto Borea: Honored to be here at Texas Lung 25 as one of the 10 winners of the poster competition
Blog
Apr 14, 2025, 08:38
European School of Oncology - Applications are open for Basic Principles in Oncology Course
Blog
Apr 14, 2025, 08:32
Norman Sharpless: ACS and ACS-CAN are now seeking an exceptional executive to serve as Chief Executive Officer
Opinion
Apr 14, 2025, 08:30
Ilaya Kumar: What if understanding antigen-presenting cells could change how we treat lung cancer?
Blog
Apr 14, 2025, 08:25
Stephen V Liu: Xiuning Le's discussed 1L therapy in EGFR NSCLC at Texas Lung 25
Blog
Apr 14, 2025, 08:25
Miriam Mutebi: Married to the Mission - A Perspective on Kenya’s Breast Cancer Crisis
Blog
Apr 14, 2025, 08:24
Mikkael A. Sekeres: MPN-MDS Meeting in Austin With OG MDSsm Superstar Doctors
Insight
Apr 14, 2025, 08:10
Most viewed in the last 7 days from JAMA Oncology: Selective Elimination of Breast Surgery for Invasive Breast Cancer
Blog
Apr 14, 2025, 08:10
Moy Bracken: Unlocking Affordability and Access with HEOR
Career
Apr 14, 2025, 08:09
Daniel De Carvalho: I’m incredibly honoured to receive the Gairdner award
Blog
Apr 14, 2025, 08:06
Elvina Almuradova: The recent FDA approval of larotrectinib reminds that NTRK fusions can occur across many tumor types